We are international
Donate
TEXT SIZE   


A Randomized Phase I Study of Melphalan and Bortezomib for Autologous Transplant in Myeloma
By Jonathan Kaufman, M.D.
XIIth International Myeloma Workshop in Washington, DC
Jonathan Kaufman, M.D.
Winship Cancer Institute
Emory University
Atlanta, Georgia
02.23.09


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles